Drug reference directory
Drug reference

tagraxofusp

cytokine-cytotoxin conjugate (IL-3 and diphtheria toxin) · anticancer

cytokine-cytotoxin conjugate (IL-3 and diphtheria toxin)anticancer
CDSCO approved
EXCRETION
—
not curated
INTERACTIONS
7 major
SEVERE in our sources
PREGNANCY
—
not curated
Top interactionssee all 7 →
  • ClozapineSevereDatabaseDDInter
  • DeferiproneSevereDatabaseDDInter
  • LeflunomideSevereDatabaseDDInter
  • LomitapideSevereDatabaseDDInter

Mechanism

Tagraxofusp is a fusion protein of human IL-3 and truncated diphtheria toxin that is directed to cells expressing the IL-3 receptor (CD123). It inhibits protein synthesis and causes cell death.

Indications

plasmacytoid dendritic cell neoplasm

Side effects

Serious
  • capillary leak syndrome

Drug interactions

Clozapine
Severe
Database

Drug interaction classified as: synergy

Source: DDInter

Deferiprone
Severe
Database

Clinical effect not specified

Source: DDInter

Leflunomide
Severe
Database

Clinical effect not specified

Source: DDInter

Lomitapide
Severe
Database

Clinical effect not specified

Source: DDInter

Mipomersen
Severe
Database

Clinical effect not specified

Source: DDInter

Pexidartinib
Severe
Database

Clinical effect not specified

Source: DDInter

Teriflunomide
Severe
Database

Clinical effect not specified

Source: DDInter

5 additional unreviewed or low-confidence interactions hidden because their provenance or source detail is insufficient.

Ask House about tagraxofusp

Continue into a citation-backed clinical answer with the drug context already attached.

Textbook-sourced·Sources: Goodman & Gilman 14e·Updated: 2026-05-10